Tags: Clinical Trials

blog

Top 5 Advances in 2018

In 2018 we have seen increased investments in Alzheimer's biomarkers and increased interest in prevention.

announcements

Ryan Institute for Neuroscience Receives Approval for Groundbreaking Clinical Trial

The ADDF-funded BEACON Study at the George & Anne Ryan Institute of Neuroscience received regulatory approval to conduct a clinical trial.

announcements

New Funding Focuses on Prevention

The Alzheimer's Drug Discovery Foundation awarded new funding to studies that focus on prevention.

announcements

New Generation of Therapeutics Based on Understanding of Aging Biology Show Promise for Alzheimer's

A review by the ADDF published in Neurology® explores novel approaches beyond the common amyloid that could slow or prevent Alzheimer's.

blog

Two Decades of Research: The ADDF's 19th International Conference on Alzheimer’s Drug Discovery

Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.

announcements

Dr. Michela Gallagher Wins Alzheimer's Drug Discovery Foundation's Prestigious Goodes Prize

Michele Gallagher, PhD, is the recipient of the fourth Melvin R. Goodes Prize, which includes a $150,000 award to support the therapeutic development of AGB-101.

announcements

$2.3 Million in New Funding Focused on Novel Biomarkers and Treatments

The Alzheimer's Drug Discovery Foundation (ADDF) announces funding for a novel biomarker and two Phase I clinical studies.

announcements

New Investments Fund Research Ranging from Novel Treatments for Postoperative Cognitive Dysfunction

The Alzheimer's Drug Discovery Foundation (ADDF) announces seven new investments, including clinical trials, novel drug programs, and a prevention program, which reflects the comprehensive nature of the ADDF's funding strategy.

announcements

$2.5 Million in New Funding Exemplifies ADDF’s Strategy

We announce $2.5 million in new funding, which reflects the comprehensive nature of our strategy to prevent and treat Alzheimer’s disease. 

blog

Alzheimer’s Clinical Trials, Explained

Learn about clinical trials, an important and growing part of our funding at the Alzheimer’s Drug Discovery Foundation.